Healthpeak Properties (DOC) closed at $19.48 on November 2, 2026, up 2.4% from the previous close, on volume of 8,645,548 shares (30-day average 5,600,998).
Data as of November 2, 2026.
2-Nov-2026
Healthpeak Properties' Q3 FFO declines Y/Y, 2026 guidance raised
Seeking Alpha News (Mon, 2-Nov 4:35 PM ET)
Healthpeak Reports Third-Quarter Results and Strong Senior Housing Growth
TipRanks (Mon, 2-Nov 4:32 PM ET)
Healthpeak Properties FFO of $0.43 in-line, revenue of $820.89M beats by $77.38M
Seeking Alpha News (Mon, 2-Nov 4:13 PM ET)
Business Wire (Mon, 2-Nov 4:05 PM ET)
Here are the major earnings after the close Monday
Seeking Alpha News (Mon, 2-Nov 9:00 AM ET)
Healthpeak Properties Q3 2026 Earnings Preview
Seeking Alpha News (Sun, 1-Nov 5:35 PM ET)
Business Wire (Thu, 1-Oct 4:16 PM ET)
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Fourth Quarter of 2026
Business Wire (Thu, 1-Oct 4:15 PM ET)
Globe Newswire (Tue, 1-Sep 8:30 AM ET)
Business Wire (Tue, 4-Aug 4:15 PM ET)
Healthpeak owns a diversified healthcare portfolio of nearly 700 in-place properties spread across mainly medical office and life science assets, plus a small portfolio of senior housing properties owned through the company's equity investment in Janus Living.
Healthpeak Properties trades on the NYSE stock market under the symbol DOC.
As of November 2, 2026, DOC stock price climbed to $19.48 with 8,645,548 million shares trading.
DOC has a beta of 0.04, meaning it tends to be less sensitive to market movements. DOC has a correlation of 0.00 to the broad based SPY ETF.
DOC has a market cap of $13.43 billion. This is considered a Large Cap stock.
Last quarter Healthpeak Properties reported $772 million in Revenue and $.46 earnings per share. This beat revenue expectation by $58 million and exceeded earnings estimates by $.02.
In the last 3 years, DOC traded as high as $23.26 and as low as $10.52.
The top ETF exchange traded funds that DOC belongs to (by Net Assets): VNQ, VTI, VOO, VB, VBR.
DOC has outperformed the market in the last year with a price return of +17.8% while the SPY ETF gained +11.7%. However, in the short term, DOC had mixed performance relative to the market. It has underperformed in the last 3 months, returning -10.3% vs +1.7% return in SPY. But in the last 2 weeks, DOC shares have fared better than the market returning +3.7% compared to SPY -1.5%.
DOC support price is $18.71 and resistance is $19.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOC shares will trade within this expected range on the day.
